Arrowhead Research Corporation (ARWR)
Health Care ยท Pharmaceutical Preparations
Arrowhead Research Corporation (ARWR) is listed on Nasdaq, where its shares have traded since February 1, 1995. SentiSense covers Arrowhead Research Corporation in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations. Christopher Anzalone is its chief executive officer. The company reports 711 employees, and its corporate website is www.arrowheadpharma.com.
About Arrowhead Research Corporation
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
Latest reported results
Arrowhead Pharmaceuticals Inc. reported revenue of $75.3 million for Q3 FY2026, up 171.0% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 489 institutions reported holding ARWR, with 119.1 million shares worth $9.7 billion in aggregate. The largest reported holders were BlackRock, Vanguard and Avoro Capital Advisors. Of the 5 largest reported holders, 2 added shares and 3 reduced their positions during the quarter.
More on ARWR
- ARWR sentiment: whether news and social coverage of Arrowhead Research Corporation leans bullish or bearish, and the stories driving it.
- ARWR ownership: all 489 reporting institutions, plus insider and congressional trades.
- ARWR financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.
SentiSense also tracks daily options readings for Arrowhead Research Corporation: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Arrowhead Research Corporation do?
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction.
What sector is ARWR in?
SentiSense classifies Arrowhead Research Corporation in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations.
Where does ARWR stock trade?
Arrowhead Research Corporation (ARWR) is listed on Nasdaq, where its shares have traded since February 1, 1995.
Who is the CEO of Arrowhead Research Corporation?
Christopher Anzalone is the chief executive officer of Arrowhead Research Corporation.